Fused ring heterocycles as potassium channel modulators

Details for Australian Patent Application No. 2004272104 (hide)

Owner ICAgen, Inc

Inventors Amato, George Salvatore; McnaughtonSmith, Grant Andrew; Thomas, James Barnwell Jr.

Agent Pizzeys

Pub. Number AU-B-2004272104

PCT Pub. Number WO2005/025293

Priority 60/502,109 10.09.03 US

Filing date 10 September 2004

Wipo publication date 24 March 2005

Acceptance publication date 8 September 2011

International Classifications

C07D 239/92 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 285/24 (2006.01) Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 498/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 513/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

Event Publications

9 March 2006 PCT application entered the National Phase

  PCT publication WO2005/025293 Priority application(s): WO2005/025293

8 September 2011 Application Accepted

  Published as AU-B-2004272104

19 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004272105-Cobalamin conjugates for anti-tumor therapy

2004272102-Methods for risk assessment, survival prediction and treatment of heart failure and other conditions based on adrenergic receptor polymorphisms